OLMA

Olema Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth↓ 1/10
  • Value↑ 6/10
Olema Pharmaceuticals sales and earnings growth
OLMA Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 15.00%
  • FCF Y/Y↓ -40.38%
Olema Pharmaceuticals gross and profit margin trends
OLMA Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -57.47%
Olema Pharmaceuticals net debt vs free cash flow
OLMA Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Olema Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗